Behavioural interventions for reducing weight gain in schizophrenia

[1]  G. Remington,et al.  Pharmacological interventions for reducing weight gain in schizophrenia , 2014 .

[2]  J. Kenardy,et al.  Psychological interventions for overweight or obesity. , 2014, The Cochrane database of systematic reviews.

[3]  P. McGuire,et al.  The dietary pattern of patients with schizophrenia: a systematic review. , 2013, Journal of psychiatric research.

[4]  Jacqueline M. Caemmerer,et al.  Acute and maintenance effects of non-pharmacologic interventions for antipsychotic associated weight gain and metabolic abnormalities: A meta-analytic comparison of randomized controlled trials , 2012, Schizophrenia Research.

[5]  J. Martínez-Ortega,et al.  Overweight and obesity in patients with bipolar disorder or schizophrenia compared with a non-psychiatric sample , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[6]  Marc De Hert,et al.  Metabolic and cardiovascular adverse effects associated with antipsychotic drugs , 2012, Nature Reviews Endocrinology.

[7]  D. Vancampfort,et al.  Relationships between obesity, functional exercise capacity, physical activity participation and physical self‐perception in people with schizophrenia , 2011, Acta psychiatrica Scandinavica.

[8]  G. Faulkner,et al.  Exercise therapy for schizophrenia. , 2010, Schizophrenia bulletin.

[9]  C. Adams,et al.  LOSS TO OUTCOMES STAKEHOLDER SURVEY: THE LOSS STUDY , 2010, Schizophrenia Research.

[10]  C. Correll,et al.  Effectiveness of Medications Used to Attenuate Antipsychotic-Related Weight Gain and Metabolic Abnormalities: A Systematic Review and Meta-Analysis , 2010, Neuropsychopharmacology.

[11]  J. Hutton.  Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials , 2009, British journal of haematology.

[12]  C. Adams,et al.  Losing participants before the trial ends erodes credibility of findings , 2009 .

[13]  S. Saha,et al.  A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? , 2007, Archives of general psychiatry.

[14]  G. Remington,et al.  Body mass index, waist circumference and quality of life in individuals with schizophrenia , 2007, Schizophrenia Research.

[15]  G. Remington,et al.  Interventions to reduce weight gain in schizophrenia. , 2007, Schizophrenia bulletin.

[16]  John M Davis,et al.  Is the superior efficacy of new generation antipsychotics an artifact of LOCF? , 2006, Schizophrenia bulletin.

[17]  J. Lieberman,et al.  A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls , 2005, Schizophrenia Research.

[18]  F. Dickerson,et al.  Physical Activity Patterns in Adults With Severe Mental Illness , 2005, The Journal of nervous and mental disease.

[19]  D. Goff,et al.  Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study. , 2005, The Journal of clinical psychiatry.

[20]  M. Järvelin,et al.  A 4-fold risk of metabolic syndrome in patients with schizophrenia: the Northern Finland 1966 Birth Cohort study. , 2005, The Journal of clinical psychiatry.

[21]  A. Qaseem,et al.  Pharmacologic and Surgical Management of Obesity in Primary Care: A Clinical Practice Guideline from the American College of Physicians , 2005, Annals of Internal Medicine.

[22]  J. de Leon,et al.  Obesity and associated complications in patients with severe mental illnesses: a cross-sectional survey. , 2005, The Journal of clinical psychiatry.

[23]  A. Young,et al.  Prevalence of obesity, glucose homeostasis disorders and metabolic syndrome in psychiatric patients taking typical or atypical antipsychotic drugs: a cross-sectional study , 2005, Diabetologia.

[24]  E. Rimm,et al.  Alcohol and Risk for Ischemic Stroke in Men: The Role of Drinking Patterns and Usual Beverage , 2005, Annals of Internal Medicine.

[25]  M. De Hert,et al.  Belgian consensus on metabolic problems associated with atypical antipsychotics , 2005, International journal of psychiatry in clinical practice.

[26]  D. Wirshing.  Schizophrenia and obesity: impact of antipsychotic medications. , 2004, The Journal of clinical psychiatry.

[27]  G. Remington,et al.  Characterizing Coronary Heart Disease Risk in Chronic Schizophrenia: High Prevalence of the Metabolic Syndrome , 2004, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[28]  J. Racoosin,et al.  Consensus development conference on antipsychotic drugs and obesity and diabetes: response to consensus statement. , 2004, Diabetes care.

[29]  J. Ananth,et al.  A typical Antipsychotic Induced Weight Gain: Pathophysiology and Management , 2004 .

[30]  D. Castle,et al.  Obesity in Schizophrenia: What can be Done About it? , 2004, Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists.

[31]  P. Crookes,et al.  Surgical Treatment of Morbid Obesity in Schizophrenic Patients , 2004, Obesity surgery.

[32]  P. Weiden,et al.  Obesity as a risk factor for antipsychotic noncompliance , 2004, Schizophrenia Research.

[33]  D. Ford,et al.  Prevalence and Correlates of Obesity in a Community Sample of Individuals with Severe and Persistent Mental Illness , 2003, The Journal of nervous and mental disease.

[34]  G. Faulkner,et al.  Schizophrenia and weight management: a systematic review of interventions to control weight , 2003, Acta psychiatrica Scandinavica.

[35]  D. Foxcroft,et al.  Exercise therapy for schizophrenia , 2003 .

[36]  S. Wessely,et al.  Behavioural management of antipsychotic‐induced weight gain: a review , 2003, Acta psychiatrica Scandinavica.

[37]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[38]  R. Ganguli,et al.  Body mass index and quality of life in community-dwelling patients with schizophrenia , 2003, Schizophrenia Research.

[39]  D. Allison,et al.  The impact of weight gain on quality of life among persons with schizophrenia. , 2003, Psychiatric services.

[40]  J. Birt.  Management of Weight Gain Associated with Antipsychotics , 2003, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[41]  Abdullah Al Mamun,et al.  Obesity in Adulthood and Its Consequences for Life Expectancy: A Life-Table Analysis , 2003, Annals of Internal Medicine.

[42]  S. Beaulieu,et al.  Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives. , 2002, Pharmacopsychiatry.

[43]  Allan Donner,et al.  Issues in the meta‐analysis of cluster randomized trials , 2002, Statistics in medicine.

[44]  U. Werneke,et al.  Options for pharmacological management of obesity in patients treated with atypical antipsychotics , 2002, International clinical psychopharmacology.

[45]  D. Allison,et al.  Changes in body mass index for individuals with and without schizophrenia, 1987–1996 , 2002, Schizophrenia Research.

[46]  J. Kenardy,et al.  Psychological interventions for obesity , 2002 .

[47]  Douglas G Altman,et al.  Meta-analyses involving cross-over trials: methodological issues. , 2002, International journal of epidemiology.

[48]  D. Osborn,et al.  The poor physical health of people with mental illness. , 2001, The Western journal of medicine.

[49]  Shalom Coodin,et al.  Body Mass Index in Persons with Schizophrenia , 2001, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[50]  W. Fleischhacker,et al.  The clinical implications of weight gain in schizophrenia. , 2001, The Journal of clinical psychiatry.

[51]  D. Allison,et al.  Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate , 2001, Psychiatry Research.

[52]  P. L. Fevre,et al.  Improving the Physical Health of Patients with Schizophrenia: Therapeutic Nihilism or Realism? , 2001 .

[53]  D. Allison,et al.  Weight gain from novel antipsychotic drugs: need for action. , 2000, General hospital psychiatry.

[54]  C. Adams,et al.  Unpublished rating scales: A major source of bias in randomised controlled trials of treatments for schizophrenia , 2000, British Journal of Psychiatry.

[55]  P. Weiden,et al.  Antipsychotic-induced weight gain: a comprehensive research synthesis. , 1999, The American journal of psychiatry.

[56]  J. Kampert,et al.  Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. , 1999, JAMA.

[57]  J. Birtwistle,et al.  The unhealthy lifestyle of people with schizophrenia , 1999, Psychological Medicine.

[58]  S. Chinn,et al.  Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994. , 1999, American journal of epidemiology.

[59]  G. Mckenna,et al.  Lesson of the week: Subjective change in ejaculate as symptom of infection with Schistosoma haematobium in travellers , 1997 .

[60]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[61]  J Martin Bland,et al.  Trials randomised in clusters , 1997, BMJ.

[62]  D G Altman,et al.  Statistics Notes: Detecting skewness from summary information , 1996, BMJ.

[63]  Linda M. Frazier,et al.  The unit of analysis error in studies about physicians’ patient care behavior , 1992, Journal of General Internal Medicine.

[64]  T. Silverstone,et al.  Prevalence of Obesity in Patients Receiving Depot Antipsychotics , 1988, British Journal of Psychiatry.

[65]  A. Oxman,et al.  Chapter 12: Interpreting results and drawing conclusions , 2011 .

[66]  G. Reynolds,et al.  Metabolic side effects of antipsychotic drug treatment--pharmacological mechanisms. , 2010, Pharmacology & therapeutics.

[67]  C. Loh,et al.  A comprehensive review of behavioral interventions for weight management in schizophrenia. , 2006, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[68]  Andrea Cipriani,et al.  Imputing missing standard deviations in meta-analyses can provide accurate results. , 2006, Journal of clinical epidemiology.

[69]  J. Newcomer,et al.  Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia. , 2004, The Journal of clinical psychiatry.

[70]  R. Ganguli,et al.  Nutritional assessment of patients with schizophrenia: a preliminary study. , 2003, Schizophrenia bulletin.

[71]  R. Milne,et al.  Positron emission tomography: establishing priorities for health technology assessment. , 1999, Health technology assessment.

[72]  S. Biddle,et al.  Exercise as an adjunct treatment for schizophrenia: A review of the literature , 1999 .

[73]  J. Sterne,et al.  Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review. , 1999, Health technology assessment.

[74]  M. Buyse,et al.  [The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use]. , 1999, Therapie.